Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens.

Salvatore MartiniMariantonietta PisaturoAntonio RussoMaria Grazia PalamoneMaria Teresa RussoVerdiana ZolloPaolo Maggi Nicola Coppola

Published in: Pathogens (Basel, Switzerland) (2023)

Our real-life data show that patients treated with PIs have a trend of developing both greater dyslipidemia and increased pathological IMT and atheromatous plaques These findings may be useful to optimize antiretrovirals for patients with cardiovascular risk factors.

Keyphrases

cardiovascular risk factors
hiv infected
antiretroviral therapy
cardiovascular disease
metabolic syndrome
human immunodeficiency virus
hiv positive
hiv aids
optical coherence tomography
hiv infected patients
electronic health record
type diabetes
big data
deep learning